Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques
Randomized Controlled Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques
1 other identifier
interventional
32
1 country
1
Brief Summary
Endobronchial ultrasound-guided transbronchial fine needle aspiration (EBUS-TBNA) techniques have not been well studied. The investigators will conduct a randomized study comparing the diagnostic yield and specimen quality of EBUS-FNA performed with and without suction applied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable lung-cancer
Started Dec 2012
Typical duration for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2012
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedFirst Posted
Study publicly available on registry
December 5, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2017
CompletedSeptember 21, 2020
September 1, 2020
3.1 years
November 27, 2012
September 18, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Sensitivity of each needle aspiration technique for diagnosis of malignancy
A pathologist blinded to the needle aspiration technique will review the specimen obtained from each needle aspiration and will assess for presence of malignant cells. The sensitivity for diagnosing malignancy will be calculated and compared for the two needle aspiration technique.
Diagnosis of malignancy will be ascertained after 6 month clinical follow up
Diagnostic accuracy of each needle aspiration technique for diagnosis of malignancy
A pathologist blinded to the needle aspiration technique will review the specimen obtained from each needle aspiration and will assess for presence of malignant cells. The diagnostic accuracy for diagnosing malignancy will be assessed and compared for the two needle aspiration technique.
Diagnosis of malignancy will be ascertained after 6 month clinical follow up
Secondary Outcomes (4)
Adequacy of the needle aspiration sample
Adequacy will be assessed within 1 week from procedure
Negative predicted value of each needle aspiration technique for diagnosis of malignancy
Diagnosis of malignancy will be ascertained after 6 month of clinical follow up
Specificity of each needle aspiration technique for diagnosis of malignancy
Diagnosis of malignancy will be ascertained after 6 month clinical follow up
Positive predicted value of each needle aspiration technique for diagnosis of malignancy
Diagnosis of Malignancy will be ascertained after 6 month of clinical follow up
Study Arms (2)
EBUS guided FNA with suction
ACTIVE COMPARATORDevice/procedure: lymph node tissue collection using fine needle aspiration with suction applied. Four fine needle aspirations will be taken sequentially from each lymph node. Two with suction and two without suction applied.
EBUS guided FNA without suction
EXPERIMENTALDevice/procedure: lymph node tissue collection using fine needle aspiration without suction applied. Four fine needle aspirations will be taken sequentially from each lymph node. Two with suction and two without suction applied.
Interventions
Device/procedure: lymph node tissue collection using needle with and without suction applied. Four fine needle aspirations will be taken from each lymph node. Two with suction and two without suction applied.
Eligibility Criteria
You may qualify if:
- Adult undergoing EBUS at AUBMC for suspected malignancy
You may not qualify if:
- Coagulopathy
- The lesion cannot be sampled because of intervening tumor or blood vessels.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
American University of Beirut
Beirut, Lebanon
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hassan Chami, MD
American University of Beirut Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 27, 2012
First Posted
December 5, 2012
Study Start
December 1, 2012
Primary Completion
January 1, 2016
Study Completion
January 1, 2017
Last Updated
September 21, 2020
Record last verified: 2020-09